These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8481171)

  • 1. Prediction of response to antidepressant medication by a sign-based index of melancholia.
    Parker G; Hadzi-Pavlovic D
    Aust N Z J Psychiatry; 1993 Mar; 27(1):56-61. PubMed ID: 8481171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining antidepressants and psychotherapy: rationale and strategies.
    Perry S
    J Clin Psychiatry; 1990 Jan; 51 Suppl():16-20. PubMed ID: 2403999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response in melancholia.
    Brown WA
    Acta Psychiatr Scand Suppl; 2007; (433):125-9. PubMed ID: 17280578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive performance in patients recovering from depression.
    Kuny S; Stassen HH
    Psychopathology; 1995; 28(4):190-207. PubMed ID: 7480575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of ECT response: validation of a refined sign-based (CORE) system for defining melancholia.
    Hickie I; Mason C; Parker G; Brodaty H
    Br J Psychiatry; 1996 Jul; 169(1):68-74. PubMed ID: 8818371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features.
    Zaninotto L; Souery D; Calati R; Sentissi O; Kasper S; Akimova E; Zohar J; Montgomery S; Mendlewicz J; Serretti A
    Ann Clin Psychiatry; 2013 May; 25(2):97-106. PubMed ID: 23638440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotic depression: a review and clinical experience.
    Parker G; Hadzi-Pavlovic D; Hickie I; Mitchell P; Wilhelm K; Brodaty H; Boyce P; Eyers K; Pedic F
    Aust N Z J Psychiatry; 1991 Jun; 25(2):169-80. PubMed ID: 1678937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melancholic/endogenous depression and response to somatic treatment and placebo.
    Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
    Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotic depression: advances in conceptualization and treatment.
    Dubovsky SL; Thomas M
    Hosp Community Psychiatry; 1992 Dec; 43(12):1189-98. PubMed ID: 1360938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
    Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
    Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent depression without lithium therapy. A lost chance].
    Pascalis JG; Perceau A; Brochier T
    Ann Med Psychol (Paris); 1993; 151(7):510-1. PubMed ID: 8279738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants.
    Perry W; Viglione DJ
    J Pers Assess; 1991 Jun; 56(3):487-501. PubMed ID: 1865307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Sullivan PF; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):376-83. PubMed ID: 12060187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properties and utility of the CORE measure of melancholia.
    Parker G; McCraw S
    J Affect Disord; 2017 Jan; 207():128-135. PubMed ID: 27721186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cognitive behaviour therapy of benefit for melancholic depression?
    Gilfillan D; Parker G; Sheppard E; Manicavasagar V; Paterson A; Blanch B; McCraw S
    Compr Psychiatry; 2014 May; 55(4):856-60. PubMed ID: 24461162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining melancholia: the primacy of psychomotor disturbance.
    Parker G
    Acta Psychiatr Scand Suppl; 2007; (433):21-30. PubMed ID: 17280567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathologic personality, temperament and treatment].
    Akiskal HS
    Encephale; 1995 Mar; 21 Spec No 2():47-9. PubMed ID: 7588180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical criteria for choosing an antidepressive drug].
    Manus A
    Encephale; 1995 Dec; 21 Spec No 4():19-21. PubMed ID: 8808341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.